Page last updated: 2024-11-01

niclosamide and Autosomal Dominant Juvenile Parkinson Disease

niclosamide has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barini, E1
Miccoli, A1
Tinarelli, F1
Mulholland, K1
Kadri, H1
Khanim, F1
Stojanovski, L1
Read, KD1
Burness, K1
Blow, JJ1
Mehellou, Y1
Muqit, MMK1

Other Studies

1 other study available for niclosamide and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1.
    Chembiochem : a European journal of chemical biology, 2018, 03-02, Volume: 19, Issue:5

    Topics: Anthelmintics; Drug Discovery; Enzyme Activators; HeLa Cells; Humans; Membrane Potential, Mitochondr

2018